GGrantIndex
Sort

53,477 grants matching addiction

Huntington's Disease and the Striatum

$423,750
Michelle E Ehrlich · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · NS

Building novel vaccines on a borrowed coat

$423,750
F. Nina Papavasiliou · Rockefeller University · R01 · FY2011 · AI

Building novel vaccines on a borrowed coat

$423,750
F. Nina Papavasiliou · Rockefeller University · R01 · FY2015 · AI

Neurochemistry of Opiate Abuse Risk in Chronic Pain

$423,741
Jon-Kar Zubieta · University Of Michigan At Ann Arbor · R01 · FY2010 · DA

Administrative Core

$423,713
Ralph E Tarter · University Of Pittsburgh At Pittsburgh · P50 · FY2008 · DA

PET ligand development for mGlu2 based on negative allosteric modulators

$423,576
Steven H Liang · Massachusetts General Hospital · R01 · FY2018 · MH

Neuropeptide S Receptor 1 as a Novel Target for Reducing Opioid Self-Administration and Opioid Relapse

$423,500
Brendan Tunstall · University Of Tennessee Health Sci Ctr · R21 · FY2024 · DA

Membrane Trafficking of Opioid and Adrenergic Receptors

$423,489
Mark E. Von Zastrow · University Of California, San Francisco · R01 · FY2014 · DA

Targeted tobacco regulatory science: Nicotine dose effects in animal models of smoking initiation in vulnerable adolescent subpopulations

$423,477
Mark G Lesage · Hennepin Healthcare Research Institute · R01 · FY2018 · DA

Calcium channels, newborn neurons, and CNS circuit dynamics

$423,437
Karl Alexander Deisseroth · Stanford University · R01 · FY2011 · DA

Calcium channels, newborn neurons, and CNS circuit dynamics

$423,437
Karl Alexander Deisseroth · Stanford University · R01 · FY2014 · DA

Calcium channels, newborn neurons, and CNS circuit dynamics

$423,437
Karl Alexander Deisseroth · Stanford University · R01 · FY2012 · DA

RCMI Administrative Core

$423,430
Ezemenari M Obasi · University Of Houston · U54 · FY2024 · MD

Understanding addiction vulnerability genes

$423,424
George R Uhl · National Institute On Drug Abuse · Z01 · FY2007 · DA

Medical marijuana: Longitudinal trajectories in use, pain and functioning

$423,398
Mark A. Ilgen · University Of Michigan At Ann Arbor · R01 · FY2016 · DA

Alpha Adrenergic Pharmacotherapy for Polydrug (Stimulant/Opiate) Abuse

$423,362
Jack Bergman · Mclean Hospital · R01 · FY2016 · DA

Retinoic acid signaling: a novel factor for addiction-related behavior

$423,344
Thomas Arthur Green · University Of Texas Med Br Galveston · R01 · FY2022 · DA

Targeting tobacco cessation during treatment for cannabis use disorders

$423,316
Alan Jeffrey Budney · Dartmouth College · R01 · FY2012 · DA

AI-driven in vivo profiling in zebrafish: a platform for alcohol use disorder therapeutic discovery

$423,313
Lu Chen · Biosymetrics, Inc. · R42 · FY2025 · AA

D3 Receptor Compounds for the Treatment of Psychostimulant Abuse

$423,289
Robert R Luedtke · University Of North Texas Hlth Sci Ctr · R01 · FY2010 · DA

Development and Testing of Adolescent Twelve-Step Facilitation

$423,268
John F Kelly · Massachusetts General Hospital · R01 · FY2012 · AA

Basic Science Training Program in Drug Abuse

$423,237
Amelia J Eisch · Ut Southwestern Medical Center · T32 · FY2012 · DA

Product Evaluation and Manipulation Core (PEMC)

$423,141
Ahmad El Hellani · Ohio State University · U54 · FY2025 · CA

Targeting Drug-Resistant Cancer Stem Cell Niches of Gastrointestinal Stromal Tumor

$423,106
Jason Keith Sicklick · University Of California, San Diego · R01 · FY2020 · CA

Electrophysiological and electrochemical studues of addictive drugs

$423,095
Eugene A Kiyatkin · National Institute On Drug Abuse · ZIA · FY2016 · DA